BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
glucose metabolic process
,
HIV infection
,
Lymphocyte
,
Anticancer prodrugs
,
Lipitor
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
cpg odns
Summary
General Info
Curated Studies
Most Correlated Studies
Whole blood of IRAK4-null, MYD88-null and normal donors treated with Toll-like receptor agonists
Gene expression of PBMCs treated with CpG oligodeoxynucleotides or LPS
The anti-inflammatory nature of HDL in macrophages
Dendritic cells bone-marrow derived treated with toll-like receptor ligands LPS and CpG
Plasmacytoid dendritic cells treated with CpG-C and imiquimod
Explore Curated Studies Results
Literature
Most Relevant Literature
CpG ODN 2102 promotes antibacterial immune responses and enhances vaccine-induced protection in gold…
Class-B CpG-ODN Formulated With a Nanostructure Induces Type I Interferons-Dependent and CD4+ T Cell…
TLR9 mediates S. aureus killing inside osteoblasts via induction of oxidative stress.
Effects of in ovo injection of bacterial peptides and CpG-ODN on Salmonella enterica serovar Heidelb…
Glycogen for lysosome-targeted CpG ODNs delivery and enhanced cancer immunotherapy.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Intratumor CpG-ODN Boosters Immune Killing Against in Situ Tumor Antigen Release for Advanced Solid …
Randomized Phase 2 With CpG-ODN in Malignant Glioblastoma
Safety and Immunogenicity Study of Na-GST-1 With or Without CpG
AMA1-C1/Alhydrogel + CpG 7909 for Malaria
CpG 7909 in Treating Patients Who Have Undergone Autologous Stem Cell Transplant
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ